LOSARTAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Losartan, and what generic alternatives are available?
Losartan is a drug marketed by Aiping Pharm Inc, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, Zydus Pharms Usa Inc, Apotex, Sandoz, and Teva Pharms. and is included in forty NDAs.
The generic ingredient in LOSARTAN is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOSARTAN?
- What are the global sales for LOSARTAN?
- What is Average Wholesale Price for LOSARTAN?
Summary for LOSARTAN
US Patents: | 0 |
Applicants: | 26 |
NDAs: | 40 |
Drug Prices: | Drug price information for LOSARTAN |
Drug Sales Revenues: | Drug sales revenues for LOSARTAN |
DailyMed Link: | LOSARTAN at DailyMed |
![LOSARTAN drug patent expirations Drug patent expirations by year for LOSARTAN](/p/graph/s/t/LOSARTAN-patent-expirations.png)
![Drug Prices for LOSARTAN](/p/graph/drug-price/LOSARTAN.png)
![Drug Sales Revenue Trends for LOSARTAN](/p/graph/drug-sales-revenues/LOSARTAN.png)
US Patents and Regulatory Information for LOSARTAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic Pharms Ltd | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 091617-003 | Feb 17, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Prinston Inc | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 204901-002 | Nov 6, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Micro Labs | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 091541-002 | Sep 24, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |